Recent Updates
Recently added Catalysts
PFE Positive Sentiment

Pfizer Advances Today’s Cancer Care and Tomorrow's Potential Breakthroughs at ESMO

Monday, September 28, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Pfizer Inc. will present 45 research abstracts at the upcoming ESMO Congress in Madrid. The presentations will include 11 oral presentations highlighting advancements in cancer treatments, particularly in breast, genitourinary, and lung cancers. This event underscores Pfizer's commitment to enhancing cancer care and exploring future breakthroughs.

Market Sentiment Analysis

POSITIVE FACTORS

  • Pfizer is presenting 45 research abstracts at ESMO.
  • The company showcases advancements in cancer care.
  • Focus on established medicines and late-stage pipeline.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+6%
120-day peak, hindsight
Typical move
1.3%
average across 15 past catalysts
Lead asset
ibuzatrelvir
Phase 3 · COVID-19 Infection

Full Press Release Details

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) will present data from 45 company-sponsored, investigator-sponsored, and collaborative research abstracts at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026 in Madrid, Spain. The presentations include 11 oral presentations spanning Pfizer’s established medicines and late-stage pipeline across its disease areas of focus, including breast cancer, genitourinary cancers, and lung cancer. “At Pfizer Oncolo

Frequently Asked Questions

What is the ESMO Congress?

The ESMO Congress is a major event focused on advancements in oncology.

How many abstracts will Pfizer present at ESMO?

Pfizer will present 45 research abstracts at the ESMO Congress.

What types of cancer are highlighted by Pfizer?

Pfizer's presentations will focus on breast, genitourinary, and lung cancers.

When is the ESMO Congress taking place?

The ESMO Congress will be held from October 23-27, 2026.

ShareAdd on Google
Tags: PFE Viatris Investor Conferences Healthcare Pfizer cancer care ESMO breast cancer lung cancer
Last updated: Sep 28, 2026

Biotech snapshot

Cash runway
$11699M liquidity · $0M/mo burn
Low dilution risk
Lead asset
ibuzatrelvirPhase 3
COVID-19 Infection →

Catalyst track record

+6%
best trade around PFE's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for PFE.

See every catalyst's timing & PoA →